
Pausing longer-term hormonal therapies to have a baby will not raise a breast cancer survivor’s risk of her tumor recurring, a new clinical trial concludes. Women whose cancer is fueled by female hormones such as estrogen often are treated with medications — such as aromatase inhibitors or tamoxifen — that suppress those hormones or block… read on > read on >